CPC C07D 249/14 (2013.01) [A61K 31/4196 (2013.01); A61K 31/4245 (2013.01); A61K 31/4439 (2013.01); A61K 45/06 (2013.01); C07D 401/12 (2013.01); C07D 405/12 (2013.01); C07D 413/12 (2013.01)] | 21 Claims |
1. A compound of Formula Ia, or a pharmaceutically acceptable salt or tautomer thereof:
![]() wherein:
X is N;
A′ is independently selected from the group consisting of F, Cl, Br, I, OC(═O)N(R)2, CN, NO2, CF3, OCF3, (C1-C6)hydrocarbyl, N(R)2, SR, SOR, SO2R, SO2N(R)2, SO3R, C(═O)R, C(═O)OR, OC(═O)R, O(CH2)0-2C(═O)OR, C(═O)N(R)2, OC(═O)N(R)2, (CH2)0-2N(R)C(═O)R, N(R)SO2R, N(R)C(═O)OR, N(R)C(═O)R, N(R)C(═O)N(R)2, and C(═NH)N(R)2,
wherein each occurrence of R is independently selected from the group consisting of hydrogen and (C6-C6)hydrocarbyl; or
wherein two R groups bonded to a nitrogen atom or to adjacent nitrogen atoms can combine with the nitrogen atom or atoms to form a heterocyclyl;
R2 is:
![]() wherein:
each of Z1, Z2, Z3, Z4, and Z5 is C-A2, provided at least one of Z1 and Z5 is CH;
each occurrence of A2 is independently selected from the group consisting of
![]() F, Cl, Br, I, OR, OC(═O)N(R)2, CN, NO2, CF3, OCF3, R, N(R)2, SR, SOR, SO2R, SO2N(R)2, SO3R, C(═O)R, C(═O)OR, OC(═O)R, C2-6 alkenyl-COOR, C2-6 alkenyl-CONR2, O(CH2)0-2C(═O)OR, C(═O)N(R)2, OC(═O)N(R)2, (CH2)0-2N(R)C(═O)R, N(R)SO2R, N(R)C(═O)OR, N(R)C(═O)R, N(R)C(═O)N(R)2, and C(═NH)N(R)2,
provided at least one occurrence of A2 is not hydrogen;
wherein zero, one, or two A2 can be independently
![]() wherein Y, Z, and Q are each independently C—R5 or N, wherein each R5 is independently selected from the group consisting of H, F, Cl, Br, I, OR, OC(═O)N(R)2, CN, NO2, CF3, OCF3, R, N(R)2, SR, SOR, SO2R, SO2N(R)2, SO3R, C(═O)R, C(═O)OR, OC(═O)R, O(CH2)0-2C(═O)OR, C(═O)N(R)2, OC(═O)N(R)2, (CH2)0-2 N(R)C(═O)R, N(R)SO2R, N(R)C(═O)OR, N(R)C(═O)R, N(R)C(═O)N(R)2, and C(═NH)N(R)2;
wherein each occurrence of R is independently selected from the group consisting of hydrogen and (C6-C6)hydrocarbyl; and
m is 1, 2, 3, 4, or 5.
|